|
|
|
Volumn 74, Issue 2, 2002, Pages 81-85
|
|
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature
a
|
|
Author keywords
Advanced disease; Seminoma; Testis cancer
|
|
Indexed keywords
CISPLATIN;
IFOSFAMIDE;
VINBLASTINE;
ANTINEOPLASTIC AGENT;
BEP PROTOCOL;
BLEOMYCIN;
CARBOPLATIN;
ETOPOSIDE;
ADULT;
ADVANCED CANCER;
AGE;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
DRUG TOLERABILITY;
EVALUATION AND FOLLOW UP;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
PARAAORTIC LYMPH NODE;
RETROPERITONEAL DISEASE;
SEMINOMA;
SIDE EFFECT;
TESTIS CANCER;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CASE MANAGEMENT;
DISEASE FREE SURVIVAL;
LYMPH NODE METASTASIS;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CANCER;
ORCHIECTOMY;
PATHOLOGY;
REMISSION;
RETROPERITONEUM;
RETROSPECTIVE STUDY;
REVIEW;
RISK FACTOR;
SALVAGE THERAPY;
SURVIVAL RATE;
TESTIS TUMOR;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADULT;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CARBOPLATIN;
CASE MANAGEMENT;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
ETOPOSIDE;
FOLLOW-UP STUDIES;
HUMAN;
IFOSFAMIDE;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEOPLASM, RESIDUAL;
NEOPLASMS, MULTIPLE PRIMARY;
ORCHIECTOMY;
RADIOTHERAPY, ADJUVANT;
REMISSION INDUCTION;
RETROPERITONEAL SPACE;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SALVAGE THERAPY;
SEMINOMA;
SURVIVAL RATE;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
VINBLASTINE;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035996042
PISSN: 11243562
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (85)
|
